The development and evaluation of training programs with the potential to improve informed consent and accrual to clinical trials depend heavily on the ability to measure outcomes of these trainings. In this chapter, we present the development of an instrument, the clinical trial communication inventory (CTCI). Data were collected from 87 clinical research professionals at three academic medical centers, which were analyzed using factor analytic methods and reliability testing procedures. This testing resulted in eight subscales representing verbal, nonverbal, and privacy protection behaviors. While the final CTCI instrument would benefit from further validity testing, it represents a resource that can be used to evaluate future trainings of research professionals. 
Introduction
The abysmal rate of accrual to clinical trials, particularly among members of minority and underserved populations, has impeded medical and scientific progress [1] . Ironically, when members of marginalized populations do not participate in numbers that allow the medical community to draw conclusions about the efficacy of new treatments for members of patients in a clinical trial recruitment context can be taught [17] . The content of clinical trial communication training programs varies considerably (as do outcomes), but most programs appear to be successful in improving the confidence of those who recruit for studies [18] .
While clinical trial communication training programs are not yet widely available, there are some laudable examples that warrant discussion. Fallowfield and colleagues [19] [20] [21] have been among the first to develop communication training programs specifically focused on clinical trial recruitment and consent issues. Their training programs provided information on common communication issues and ethical concerns and were primarily directed toward physicians and nurses with clinical trial management roles. The main outcomes from these trainings were improved knowledge of clinical trials and increased confidence in their ability to recruit and consent patients. Similarly, Wells and colleagues [22] developed a training program to improve professionals' communication abilities but focused largely on developing increased cultural competency by focusing on barriers and beliefs of African Americans and Latinos. The program focused on outcomes related to knowledge and attitudes of minority patients' cultural needs. Another communication training program, developed and piloted at the University of Miami, focused on educating research coordinators on specific verbal and nonverbal communication skills to improve clinical trial recruitment and informed consent discussions. This communication training program consisted of five modules and adopted several educational strategies including a didactic presentation, in-group discussions, live demos, and role play activities [17] .
One issue that has troubled virtually all existing clinical trial communication programs is the actual assessment of training outcomes. This may be a symptom of a larger problem in that there seems to be little consensus about what the goal should be for communication trainings.
We assert that there should be two central goals: (1) increasing the willingness and ability of recruiters to use "best practices" in communication about clinical trial participation, with the ultimate goal of (2) increasing informed decision making among potential participants. Whether patients and other potential participants provide informed consent to enroll in a study or make an informed decision to decline the opportunity to participate, we believe that all patients should be presented with the choice to advance knowledge relevant to their health conditions wherever such opportunities exist. The burden is on us to communicate well in order to maximize the patients' comprehension of all factors that are relevant to their decisions.
Current assessments of the quality of communication practice as an outcome of clinical trial communication training has focused on several tools: (1) surveys of training participants' knowledge, attitudes, and perceived self-efficacy; (2) role-plays to practice skills; (3) videotaping participants to provide individualized feedback, and (4) the use of check lists to assess recruiters' behaviors when interacting with potential participants [18] . While all of these assessment strategies are valuable, none of these approaches has been validated, including the self-report survey, which is the most commonly used tool [18] . The development and evaluation of more effective training programs depend heavily on the use of validated and, preferably, triangulated outcome measures.
Toward this end, we have developed a self-report questionnaire that focuses on communication behaviors that are critical for effective clinical trial recruitment and consent. The measure is grounded in the empirical literature on clinical trial communication, particularly the work of Morgan and colleagues, who identified verbal and nonverbal communication behaviors that recruiters themselves associate with effective recruitment and consent processes [12] [13] [14] [15] .
We created an initial pool of 138* items which corresponded to a wide variety of communication behaviors including eye contact; conversational style; protection of patient privacy; tone of voice; ability to "read" patients; ability to adapt to patient communication preferences; mirroring patient communication behaviors; smiling and friendliness; body positioning; the use of touch; physical appearance; simplifying/"translating" medical and technical information into lay language; reframing or using metaphors and analogies to explain difficult concepts; encouraging question asking; balancing the presentation of risks and benefits of study participation; describing the benefits to self and society of study participation; and other communication behaviors that ensure that potential participants comprehend information that is relevant to the decision to participate in a research study or clinical trial.
Methods

Procedures
All survey items were entered into online formats including REDCap and Qualtrics for dissemination. Following institutional review board (IRB) approval, the survey was distributed to research professionals at three academic medical centers: University of Miami, University of Florida, and University of Texas Health Science Center. Because of a technical error, data from the University of Texas Health Science Center (n = 16 surveys) could not be retained for the study.
The eligibility criteria for participation were broad: Any employee whose job duties regularly involved recruiting and/or consenting patients for clinical trials or research studies could participate in the study. The survey was distributed via email link by managers within each academic medical center. No compensation for participation was offered. A total of 71 people who completed the survey were included in the analyses. Respondents had an average of 6 years of experience (M = 5.93, SD = 4.20). The demographic and professional characteristics of our sample appear in Table 1 .
Measures
In addition to the items assessing communication behaviors in clinical trial contexts, demographic questions, the nature of their work, and their level of experience, we asked research professionals about how they feel about their jobs, their motivation levels, and their selfassessment of their competence in recruiting for clinical trials and research studies. These items were used to explore the relationship between responses to these questions and selfreported communication behaviors as a way to test the capacity of the clinical trial communication inventory (CTCI) to discriminate different audience characteristics. 
Results
Because of the high ratio of survey items to number of participants, an exploratory factor analysis that included all survey items did not yield meaningful results. Breaking the survey down into smaller groups of conceptually linked items proved to be a more useful strategy. All reported exploratory factor analyses used an oblimin rotation because items representing, for example, different dimensions of nonverbal communication necessarily have a strong relationship with each other. An item was considered to be an indicator of a factor if it had a loading of .5 and a loading of no more than .4 on any other factor. The results of the exploratory factor analyses for four sets of items appear in Table 2 (nonverbal communication), Table 3 (translation, simplification, and lay language), Table 4 (reframing medical information), and Table 5 (fostering understanding of medical research). Appendix A contains the items retained for each scale.
The results of the factor analyses (where viable results were obtained) were used to construct final versions of the scales. Descriptive statistics for each of the final subscales and Cronbach's alpha appear as Table 6 . Pearson correlations between all of the CTCI subscales appear in Table 7 .
The relationships between the final CTCI subscales and other variables in the survey were examined. Specifically, we sought to look for possible difference in responses by gender, race/ 
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ethnicity, and type of trial recruited for. We also looked for correlations between responses to the CTCI subscales and job satisfaction and years of experience. None of these analyses produced a significant pattern of results except for years of experience. The number of years of experience as a research professional correlated significantly with use of eye contact (r(62) = .45, p < .001); efforts to preserve patient privacy (r(61) = .47, p < .001); translation of medical and research terminology into lay language (r(56) = .55, p < .001); the use of reframing to explain research (r(51) = .52, p < .001); fostering understanding of research concepts (r(49) = .43, p = .002); and attitudes toward answering patient questions (r(54) = .67, p < .001).
The correlation between years of experience and fostering understanding of medical research was nearly significant, r(52) = .27, p = .06. However, correlations between years of experience and the measure of mirroring and adapting to patients' nonverbal communication was nonsignificant, r(54) = −.05, p = n.s. I find it difficult to explain how randomization works in the context of the trial being offered .31 −.57 .54 Table 4 . Reframing medical information factor loadings for exploratory factor analysis with oblimin rotation.
Item 1 2
I always begin a discussion with a patient by explaining the purpose of our conversation .51 −.24
Before getting a patient's signature on a consent form, I always check their understanding of the study information .69 −.44
I ask patients to 'teach back' (or summarize for me) the key points of a study to me before they consent to being in a study I explain the concept of equipoise (trials are conducted only when there is collective uncertainty that the benefit of an experimental treatment is better than the current best practice standard treatment)
.
.49
I explain the concept of beneficence (trials are conducted to determine whether there is a significant additional benefit from the experimental treatment) .58 .60
I explain the concept of non-maleficence (there is evidence to suggest that being involved in a clinical trial will in no way worsen the patient's chances)
.68 .71 Table 5 . Fostering understanding of medical research factor loadings for exploratory factor analysis with oblimin rotation.
Discussion
This chapter presents the development and analysis of an instrument designed to evaluate the communication behaviors of professionals who recruit for clinical trials and research studies. Of the original 133 items, 44 items were retained in 8 subscales. These subscales include maintaining patient privacy; translation of medical and technical information; reframing medical and technical information; fostering understanding of research; explaining specific research concepts; question answering; nonverbal communication, including reading patients, adapting to patients' communication, their state of mind, and preferences, mirroring behaviors; and eye contact. ing results in changed scores on the CTCI from pre-to post-test, and more importantly, that scores post-training reflect improvements to informed consent with patients, which can be evaluated through patient "teach-backs" and an increased number of accurate responses to a set of study-related knowledge questions.
Conclusion
Improvement of low accrual to clinical trials and research studies is urgently needed, particularly for members of minority populations. Research has demonstrated that communication behaviors play an important role in the recruitment and consent processes. While communication behaviors can (and should) be developed through professional seminars and workshops, there are few available instruments to conduct evaluations of the outcomes of those trainings. In this chapter, we outline the development and testing of a measure of communication in clinical trial contexts: the Clinical Trial Communication Inventory. While additional testing needs to be conducted to more thoroughly establish convergent and predictive validity with multiple professional groups, we believe that this instrument will help advance the development of clinical trial communication training programs.
Based on what I know about the educational level of the patient, I adapt my explanation of a study.
Reframing medical and technical information
If it's a complex study, I often reframe information in medical terms that are more familiar to them.
I find that I often use analogies (that aren't part of the consent form) when explaining a study.
I frequently use examples as a way to explain technical information about a study.
I often give specific examples of what will happen to a patient if they join a study.
I frame unfamiliar or potentially scary concepts in terms that are more familiar or acceptable to patients.
I often use metaphors and analogies to explain randomization or other study concepts.
I use analogies to explain potentially scary tests or concepts.
Fostering understanding of research
I always begin a discussion with a patient by explaining the purpose of our conversation.
Before getting a patient's signature on a consent form, I always check their understanding of the study information.
I ask patients to 'teach back' (or summarize for me) the key points of a study to me before they consent to being in a study.
I offer patients the option of delaying their decision about study participation.
I explain to patients that the research study is being conducted to improve scientific knowledge about a particular disease, condition, or treatment.
I explain the general rationale for a randomized clinical trial (when appropriate).
When offering patients the opportunity to participate in a research study, I explain the researchers' motivations for conducting the study.
When offering patients the opportunity to participate in a research study, I tell them that all trials have to receive approval from ethics committees.
When offering patients the opportunity to participate in a research study, I acknowledge the uncertainty of treatment benefits.
Explaining specific research concepts
I explain the concept of equipoise (trials are conducted only when there is collective uncertainty that the benefit of an experimental treatment is better than the current best practice standard treatment).
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